La Iniciativa de Medicamentos Innovadores, IMI2, ha lanzado su 18ª convocatoria de propuestas financiándose los siguientes topics:
Central repository of digital pahology slides to support the development of artificial intelligence tools
Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes
Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
Accelerating research & innovation for advanced therapy medicinal products
Supporting the development of engineered T cells
La fecha límite para presentar propuestas en la primera fase es el 26 de septiembre de 2019.
Más información.